DAPT After AMI Trial - Dr. Milan Chag
Channel: Marengo CIMS Hospital
Date: 2016-03-30

"Dr. Milan Chag, Cardiologist from CIMS Hospital(Ahmedabad) discussess use of  Dual Antiplatelet Therapy (DAPT) beyond one year.All patients who undergo percutaneous coronary intervention (PCI), including those treated with balloon angioplasty without stenting, receive dual antiplatelet therapy (DAPT), which is the combination of aspirin and a P2Y12 receptor blocker to reduce the risk of myocardial infarction (MI) or cardiovascular death.In patients with prior Myocardial Infraction(MI) who are at low risk of bleeding, continuation of Dual Antiplatelet Therapy (DAPT) beyond one year offers : 
- A substantial reduction in Major Adverse Cardiac and Cerebrovascular Event(MACCE), including cardiovascular death with increased risk of major bleeding but not fatal bleeding or ICH. No increase in non CV death and Effect of extended DAPT was consistent irrespective of: - DAPT regimen, time from MI,type of MI, or PCI status."